ATXN3 and neurodegenerative disease: In sum, our results establish the significance of oligodendrocyte maturation dysfunction in SCA3 as a paradigmatic neurodegenerative disease across three SCA3 mouse models and patient post-mortem brain tissue, establishing timepoints at which oligodendrocytes could be a potential target for therapeutic intervention.